Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04122703 · ClinicalTrials.gov registry record · NA
Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction
A NA study of Female Sexual Dysfunction, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT04122703 is a NA study of Female Sexual Dysfunction that has completed, run by Stony Brook University. The registered enrollment target is 66 participants, below the 73-participant average among 4 other Female Sexual Dysfunction trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04122703, a NA study of Female Sexual Dysfunction, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand the efficacy of PTNS versus a placebo in the treatment of female sexual dysfunction syndrome.
Conditions Studied
Interventions
- DEVICE percutaneous tibial nerve stimulation (PTNS)
- DEVICE Sham procedure
Study Locations (1)
New York
- Stony Brook Medicine Women's Pelvic Health And Continence Center - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2019-09-15 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04122703
The ClinicalTrials.gov registry entry for NCT04122703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 73-participant average among 4 other Female Sexual Dysfunction trials with a reported enrollment target (10% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Female Sexual Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which percutaneous tibial nerve stimulation (PTNS) is the first listed.
NCT04122703 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04122703 about?
NCT04122703 is a clinical study titled "Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction". The purpose of this study is to understand the efficacy of PTNS versus a placebo in the treatment of female sexual dysfunction syndrome.
What is the current status of trial NCT04122703?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2019-09-15. Estimated completion is 2023-06-30.
What conditions does trial NCT04122703 study?
This clinical trial studies the following conditions: Female Sexual Dysfunction.
What interventions are being tested in trial NCT04122703?
The interventions under investigation include: percutaneous tibial nerve stimulation (PTNS) (DEVICE), Sham procedure (DEVICE).
Who is sponsoring clinical trial NCT04122703?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04122703 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Female Sexual Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
At-Home Neuromodulation for Female Sexual Dysfunction
RECRUITING · NA
-
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
COMPLETED · NA
-
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
COMPLETED · NA
-
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.